Core Viewpoint - Haleon, after its spin-off from GSK, has successfully navigated market challenges and achieved significant growth in the Chinese market, becoming a standout performer globally [3][5][30] Group 1: Company Overview and Leadership - Haleon was established as a separate entity from GSK in July 2022, inheriting well-known brands like Caltrate and Sensodyne, and has since focused on building a new operational identity [3][5] - The company has seen its market share increase for 54 consecutive months, indicating strong performance in a competitive landscape [3] - Gu Haiying, the General Manager for Mainland China and Hong Kong, emphasizes the importance of leadership and adaptability during periods of transformation [7][8] Group 2: Employee Engagement and Culture - Haleon's employee engagement index has ranked first among its global markets for three consecutive years, reflecting a strong corporate culture [10] - The company prioritizes both "hardware" (systems and processes) and "software" (team cohesion and culture) in its transformation efforts [12] - A focus on communication, trust, and teamwork has been pivotal in unifying the workforce during the integration and spin-off phases [12][13] Group 3: Strategic Initiatives and Market Position - Haleon has positioned China as one of its two "winning markets," implementing a localized decision-making strategy to enhance operational effectiveness [17][18] - The full acquisition of its OTC joint venture marks a significant milestone, allowing for complete control over its operations in China [19][22] - The company is committed to sustainable practices, achieving carbon neutrality in its Suzhou factory and implementing eco-friendly packaging initiatives [24][26] Group 4: Future Directions and Innovations - Haleon is focusing on digital transformation and AI integration, with plans to enhance operational efficiency and product development through technology [28][30] - The company aims to leverage AI not just for cost reduction but to empower and enhance workforce capabilities [28] - Looking ahead, Haleon sees significant opportunities in increasing market penetration in the consumer health sector, addressing gaps in disease occurrence and treatment rates [30]

Group 1 - Haleon showcased over 70 core products at the China International Import Expo, including 11 new products and 3 global debuts, emphasizing its deep localization strategy in the Chinese market [1] - The company aims to achieve a threefold "spillover effect" through the expo, transitioning from exhibits to products, brands to ecosystems, and local to global [3] - Haleon has established a digital health management ecosystem by collaborating with platforms like JD Health and Ping An Good Doctor, focusing on a new health consumption model that integrates products, services, and platforms [6] Group 2 - The "China Consumer Active Health Insight Report" released by Haleon indicates a shift in public health awareness in China from passive response to active management, although a gap between knowledge and action remains [4] - Haleon has enhanced its local operational capabilities through the acquisition of Tianjin SmithKline and expansion in Suzhou, aiming to create an agile operational system to better respond to market demands [6]

Core Insights - Haleon showcased over 70 core products at the China International Import Expo, emphasizing its commitment to the Chinese market with a focus on "proactive health" [1] - The company aims to leverage the expo as a platform for product innovation and to enhance consumer trust in its brand through scientific demonstrations and ESG initiatives [2] - Haleon has established deep collaborations with digital health platforms like JD Health and Ping An Good Doctor to create a new health consumption model centered on lifecycle management [3] Group 1 - Haleon presented 11 new products and 3 global debuts at the expo, highlighting its strategic localization efforts in China [1] - The company reported a shift in Chinese consumer health awareness from passive to proactive management, despite existing challenges in translating knowledge into action [2] - Digital health management tools were introduced at the expo to promote the idea that individuals are responsible for their own health [2] Group 2 - Haleon's acquisition of Tianjin SmithKline and expansion in Suzhou are aimed at enhancing local operational capabilities and creating an agile supply chain [3] - The collaboration with digital health platforms is designed to build a data-driven ecosystem focused on comprehensive health management [3] - The strategic goal of the Tianjin and Suzhou operations is to create a unified agile operating system to better respond to market demands in China [3]

Group 1 - Nearly 70% of British companies in China are optimistic about their business prospects over the next 5 to 10 years and plan to increase investments in China [1][6] - The UK is China's second-largest trading partner after the US, highlighting the importance of the Chinese market for global brands [3][6] - The shift in Chinese consumer behavior from "purchasing" to "experiencing" brands emphasizes the need for companies to focus on the experiential aspect of their products [3][5] Group 2 - The presence of social media has simplified market entry for companies, allowing them to focus on online platforms rather than traditional brick-and-mortar stores [4][5] - The Chinese government has implemented policies to boost domestic consumption and reduce market entry barriers, which are beneficial for foreign businesses [5][6] - The UK-China trade relationship is characterized by strong complementarity, with the UK being a significant investment destination for Chinese companies [6][8] Group 3 - The UK government has suspended tariffs on 89 products to alleviate the burden on businesses, which is expected to save around £17 million annually [7] - The British market, while smaller than China's, remains vibrant and open, providing opportunities for international brands [6][7] - The British Chamber of Commerce is actively working to assist small and medium-sized enterprises (SMEs) in entering the Chinese market [6]